In the current study, using an in silico approach, we identified that miR-483-5p is predicted to bind the 3′-UTR of mRNAs encoding ERK1, ERK2 and MAPT, all known to be involved in AD pathology. This evidence concerns the gene MAPT and Alzheimer disease.